search
Back to results

Self-Management Using Smartphone Application for Type2 DM in Real siTuation (SMART-DM)

Primary Purpose

Type 2 Diabetes Mellitus

Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Self-Management Using Smartphone Application for Type2 DM
self-management using booklet for management type 2 DM
Sponsored by
Inje University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring T2DM, smartphone application, serum fasting glucose, HbA1c

Eligibility Criteria

21 Years - 69 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type 2 DM using oral hypoglycemic agent
  • 6.5% < HbA1c < 10%
  • systolic blood pressure > 130 mmHg or diastolic blood pressure > 80 mmHg
  • BMI over 23.0
  • 20 < age < 70
  • smartphone user (android OS based)

Exclusion Criteria:

  • Serum fasting glucose > 250 mg/L or post prandial 2 hour serum glucose > 350 mg/L
  • systolic blood pressure > 180 mmHg or diastolic blood pressure > 110 mmHg
  • Diabetes mellitus patient using insulin
  • severe chronic diabetic complications (diabetic foot ulcer, severe diabetic retinopathy, diabetic nephropathy with severe proteinuria)
  • congestive heart failure (NYHA III-IV or left ventricular ejection fraction < 30%)
  • Aspartate aminotransferase (AST) or alanine transaminase (ALT) over 3 times of upper normal limit
  • Serum creatinine > 1.5 mg/dL
  • refusal to participate in the study
  • drug addiction or alcohol addiction
  • major psychiatric illness
  • steroid treatment or hormonal treatment with changing the drug or drug dosage in 1 month
  • changing dosage of antihypertensive agent, oral hypoglycemic agent or lipid lowering agent in 1 month
  • malignant cancer
  • pregnancy

Sites / Locations

  • Haeundae Paik Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

application arm

conventional arm

Arm Description

The patients of application arm have the smartphone application (android) for management of type 2 DM. The application contains action plans and alarm system for each situation of serum fasting glucose, blood pressure, body weight, exercise amount, calori intake, medication, etc.

The patients of conventional arm have the booklet for management of type 2 DM. The application contains general medical guideline and knowledge for management of type 2 DM such as,exercise amount, calori intake, medication, etc.

Outcomes

Primary Outcome Measures

fasting serum glucose and HbA1c
we will check the fasting serum glucose and HbA1C at the day of enrollment (day0)and those at 3months after enrollment (day 90)

Secondary Outcome Measures

body weight and BMI
we will check body weight and BMI at the day of enrollment (day0)and those at 3months after enrollment (day 90)
Lipid profile
we will check the lipid profile (total cholesterol, Triglyceride, LDL/HDL cholesterol)at the day of enrollment (day0)and those at 3months after enrollment (day 90)

Full Information

First Posted
March 26, 2013
Last Updated
November 26, 2013
Sponsor
Inje University
search

1. Study Identification

Unique Protocol Identification Number
NCT01820871
Brief Title
Self-Management Using Smartphone Application for Type2 DM in Real siTuation (SMART-DM)
Official Title
A Pilot Study of Self Management Using Application for Chronic Disease Care in Real siTuation (SMART) - DM
Study Type
Interventional

2. Study Status

Record Verification Date
November 2013
Overall Recruitment Status
Completed
Study Start Date
November 2012 (undefined)
Primary Completion Date
July 2013 (Actual)
Study Completion Date
October 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Inje University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the effectiveness of smartphone application for management of type 2 diabetes mellitus (DM). Type 2 DM is an almost incurable chronic disease and continuous management is important for long-term prognosis. However, patient's compliance to conventional medical intervention is generally unsatisfactory and many patients feel difficult to access to the detail medical advice for type 2 DM. Thus, the investigators developed a smartphone application for giving programed medical intervention to patients according to patients data; blood pressure, fasting blood sugar, body weight, calorie intake,exercise amount, etc.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
Keywords
T2DM, smartphone application, serum fasting glucose, HbA1c

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
application arm
Arm Type
Experimental
Arm Description
The patients of application arm have the smartphone application (android) for management of type 2 DM. The application contains action plans and alarm system for each situation of serum fasting glucose, blood pressure, body weight, exercise amount, calori intake, medication, etc.
Arm Title
conventional arm
Arm Type
Active Comparator
Arm Description
The patients of conventional arm have the booklet for management of type 2 DM. The application contains general medical guideline and knowledge for management of type 2 DM such as,exercise amount, calori intake, medication, etc.
Intervention Type
Other
Intervention Name(s)
Self-Management Using Smartphone Application for Type2 DM
Intervention Type
Other
Intervention Name(s)
self-management using booklet for management type 2 DM
Primary Outcome Measure Information:
Title
fasting serum glucose and HbA1c
Description
we will check the fasting serum glucose and HbA1C at the day of enrollment (day0)and those at 3months after enrollment (day 90)
Time Frame
3months after enrollemnt (day 0-day 90)
Secondary Outcome Measure Information:
Title
body weight and BMI
Description
we will check body weight and BMI at the day of enrollment (day0)and those at 3months after enrollment (day 90)
Time Frame
3months after enrollemnt (day 0-day 90)
Title
Lipid profile
Description
we will check the lipid profile (total cholesterol, Triglyceride, LDL/HDL cholesterol)at the day of enrollment (day0)and those at 3months after enrollment (day 90)
Time Frame
3months after enrollment (day 0-90)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
69 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 2 DM using oral hypoglycemic agent 6.5% < HbA1c < 10% systolic blood pressure > 130 mmHg or diastolic blood pressure > 80 mmHg BMI over 23.0 20 < age < 70 smartphone user (android OS based) Exclusion Criteria: Serum fasting glucose > 250 mg/L or post prandial 2 hour serum glucose > 350 mg/L systolic blood pressure > 180 mmHg or diastolic blood pressure > 110 mmHg Diabetes mellitus patient using insulin severe chronic diabetic complications (diabetic foot ulcer, severe diabetic retinopathy, diabetic nephropathy with severe proteinuria) congestive heart failure (NYHA III-IV or left ventricular ejection fraction < 30%) Aspartate aminotransferase (AST) or alanine transaminase (ALT) over 3 times of upper normal limit Serum creatinine > 1.5 mg/dL refusal to participate in the study drug addiction or alcohol addiction major psychiatric illness steroid treatment or hormonal treatment with changing the drug or drug dosage in 1 month changing dosage of antihypertensive agent, oral hypoglycemic agent or lipid lowering agent in 1 month malignant cancer pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jongha Park, MD
Organizational Affiliation
Inje University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Haeundae Paik Hospital
City
Busan
ZIP/Postal Code
612-030
Country
Korea, Republic of

12. IPD Sharing Statement

Learn more about this trial

Self-Management Using Smartphone Application for Type2 DM in Real siTuation (SMART-DM)

We'll reach out to this number within 24 hrs